Scott A. Armstrong

Boston Children's Hospital (US)

Research Areas

Discover Papers by Scott A. Armstrong

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

Publications

654

Citations

40382

i10-index

221

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
The Connectivity Map: Using Gene-Expression Signat...	2006	5415
MLL translocations specify a distinct gene express...	2001	1715
FoxOs Are Critical Mediators of Hematopoietic Stem...	2007	1536
Transformation from committed progenitor to leukae...	2006	1517
Mitochondria primed by death signals determine cel...	2006	1253
MLL translocations, histone modifications and leuk...	2007	1251
High-throughput oncogene mutation profiling in hum...	2007	995
Selective Killing of Mixed Lineage Leukemia Cells ...	2011	930
MLL-Rearranged Leukemia Is Dependent on Aberrant H...	2011	888
The Wnt/β-Catenin Pathway Is Required for the Deve...	2010	748

Publications

1.
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
Year: 2006Citations: 5415DOI: 10.1126/science.1132939
2.
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
Year: 2001Citations: 1715DOI: 10.1038/ng765
3.
FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress
Year: 2007Citations: 1536DOI: 10.1016/j.cell.2007.01.003
4.
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Year: 2006Citations: 1517DOI: 10.1038/nature04980
5.
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Year: 2006Citations: 1253DOI: 10.1016/j.ccr.2006.03.027
6.
MLL translocations, histone modifications and leukaemia stem-cell development
Year: 2007Citations: 1251DOI: 10.1038/nrc2253
7.
High-throughput oncogene mutation profiling in human cancer
Year: 2007Citations: 995DOI: 10.1038/ng1975
8.
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Year: 2011Citations: 930DOI: 10.1016/j.ccr.2011.06.009
9.
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Year: 2011Citations: 888DOI: 10.1016/j.ccr.2011.06.010
10.
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Year: 2010Citations: 748DOI: 10.1126/science.1186624

About Scott A. Armstrong

Scott A. Armstrong is a researcher with 654 publications and 40382 citations. They are affiliated with Boston Children's Hospital. Their research focuses on . With an h-index of 92, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Scott A. Armstrong and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year